Skip to main content
About us
Our science
Our Pipeline
Partnering
News & Events
Contact
About us
Our science
Our Pipeline
Partnering
News & Events
Contact
In the news
Press releases
Archive
Jun 10, 2024
Galimedix Therapeutics establishes Scientific Advisory Board of renowned retina experts as company prepares to enter Phase 2 clinical study with GAL-101
Apr 15, 2024
Galimedix is proud to report that the inventor of the company’s groundbreaking technology for the treatment of Alzheimer’s disease and our esteemed co-founder, Prof. Ehud Gazit, has been honored with Germany’s prestigious Meitner-Humboldt Research Award
Mar 8, 2024
Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024
Upcoming Events
LSX World Congress USA
SEPTEMBER 11-12, 2024
24th Euretina Congress
SEPTEMBER 19-22, 2024
24th Annual Biotech in Europe Forum by Sachs Associates
SEPTEMBER 25-26, 2024
Biotech on tap 2024 @Munich Oktoberfest
SEPTEMBER 25-27, 2024
American Academy of Ophthalmology Annual Meeting (AAO)
October 18-21, 2024
BIO-Europe
NOVEMBER 4-6, 2024
